Effect of connective tissue growth factor on protein kinase expression and activity in human corneal fibroblasts

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 13, 2012, Pages 8076-8085

  Radhakrishnan, Siva S ^a   Blalock, Timothy D ^a,d   Robinson, Paulette M ^a   Secker, Genevieve ^b   Daniels, Julie ^b   Grotendorst, Gary R ^c   Schultz, Gregory S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^d SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL) CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL) IMIDAZOLE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE I; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IV; CASEIN KINASE II; COLLAGEN GEL; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN DEPENDENT KINASE 9; DEATH ASSOCIATED PROTEIN KINASE; FOCAL ADHESION KINASE; G PROTEIN COUPLED RECEPTOR KINASE 2; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; JANUS KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOPROTEIN; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C; RAS PROTEIN; SALIRASIB; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA CELL; DENSITOMETRY; FIBROBLAST; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CONNECTIVE TISSUE GROWTH FACTOR; CORNEAL KERATOCYTES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN KINASES; RAS PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84873335846     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10790     Document Type: Article

References (55)

1. Bradham DM, Igarashi A, Potter RL, Grotendorst GR. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol. 1991;114:1285-1294.
2. Ryseck RP, Macdonald-Bravo H, Mattei MG, Bravo R. Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ. 1991;2:225-233.
3. Hashimoto K, Shindo-Okada N, Tani M, et al. Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses In vivo tumor growth and metastasis of K-1735 murine melanoma cells. J Exp Med. 1998;187:289-296.
4. Hurvitz JR, Suwairi WM, VanHul W, El-Shanti H, Superti-Furga A, et al. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet. 1999;23:94-98.
5. Albrecht C, von Der Kammer H, Mayhaus M, Klaudiny J, Schweizer M, Nitsch RM. Muscarinic acetylcholine receptors induce the expression of the immediate early growth regulatory gene CYR61. J Biol Chem. 2000;275:28929-28936.
6. Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH. CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol. 2000;32:1805-1819.
7. Igarashi A, Nashiro K, Kikuchi K, et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol. 1995;105:280-284.
8. Dammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S. Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol. 1998;30:909-922.
9. Wunderlich K, Senn BC, Reiser P, Pech M, Flammer J, Meyer P. Connective tissue growth factor in retrocorneal membranes and corneal scars. Ophthalmologica. 2000;214:341-346.
10. Ito Y, Aten J, Bende RJ, et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int. 1998;53: 853-861.
11. Pelton RW, Moses HL. The beta-type transforming growthfactor-mediators of cell regulation in the lung. Am Rev Respir Dis. 1990;142:S31-S35.
12. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell. 1993;4:637-645.
13. Kikuchi K, Kadono T, Ihn H, et al. Growth regulation in scleroderma fibroblasts: increased response to transforming growth factor-beta 1. J Invest Dermatol. 1995;105:128-132.
14. Grotendorst GR, Duncan MR. Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J. 2005;19:729-738.
15. Kothapalli D, Frazier KS, Welply A, Segarini PR, Grotendorst GR. Transforming growth factor beta induces anchorageindependent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ. 1997;8:61-68.
16. Daniels JT, Schultz GS, Blalock TD, et al. Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring. Am J Pathol. 2003;163:2043-2052.
17. Tamatani T, Kobayashi H, Tezuka K, et al. Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem Biophys Res Commun. 1998;251:748-752.
18. Blalock TD, Duncan MR, Varela JC, et al. Connective tissue growth factor expression and action in human corneal fibroblast cultures and rat corneas after photorefractive keratectomy. Invest Ophthalmol Vis Sci. 2003;44:1879-1887.
19. Garrett Q, Khaw PT, Blalock TD, Schultz GS, Grotendorst GR, Daniels JT. Involvement of CTGF in TGF-beta1-Stimulation of Myofibroblast Differentiation and Collagen Matrix Contraction in the Presence of Mechanical Stress. Invest Ophthalmol Vis Sci. 2004;45:1109-1116.
20. Duncan MR, Frazier KS, Abramson S, et al. Connective tissue growth factor mediates transforming growth factor betainduced collagen synthesis: down-regulation by cAMP. FASEB J. 1999;13:1774-1786.
21. Shi L, Chang Y, Yang Y, Zhang Y, Yu FS, Wu X. Activation of JNK signaling mediates connective tissue growth factor expression and scar formation in corneal wound healing. PLoS ONE. 2012;7:e32128.
22. Nishida T, Nakanishi T, Shimo T, et al. Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8). Biochem Biophys Res Commun. 1998;247:905-909.
23. Segarini P, Nesbitt D, Li D, Hayes L, Yates III J, Carmichael D. The low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem. 2001;276:40659-40667.
24. Blalock TD, Gibson DJ, Duncan MR, Tuli SS, Grotendorst GR, Schultz GS. A connective tissue growth factor signaling receptor in corneal fibroblasts. Invest Ophthalmol Vis Sci. 2012;53:3387-3394.
25. Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T, Takigawa M. CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/ extracellular-signal regulated kinase (ERK). Eur J Biochem. 2001;268:6058-6065.
26. Crean JK, Finlay D, Murphy M, et al. The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migra-tion, and actin cytoskeletal rearrangement in human mesangial cells. J Biol Chem. 2002;277:44187-44194.
27. Masterson R, Kelynack K, Hewitson T, Becker G. Effect of inhibition of farnesylation and geranylgeranylation on renal fibrogenesis in vitro. Nephron Exp Nephrol. 2006;102:e19-e29.
28. Secker GA, Shortt AJ, Sampson E, Schwarz QP, Schultz GS, Daniels JT. TGFbeta stimulated re-epithelialisation is regulated by CTGF and Ras/MEK/ERK signalling. Exp Cell Res. 2008;314: 131-142.
29. Woost PG, Jumblatt MM, Eiferman RA, Schultz GS. Growth factors and corneal endothelial cells: I. Stimulation of bovine corneal endothelial cell DNA synthesis by defined growth factors. Cornea. 1992;11:1-10.
30. Ehses JA, Pelech SL, Pederson RA, McIntosh CH. Glucosedependent insulinotropic polypeptide activates the Raf-Mek1/ 2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway. J Biol Chem. 2002;277: 37088-37097.
31. Sharma GD, He J, Bazan HE. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J Biol Chem. 2003;278:21989-21997.
32. Ebong S, Yu CR, Carper DA, Chepelinsky AB, Egwuagu CE. Activation of STAT signaling pathways and induction of suppressors of cytokine signaling (SOCS) proteins in mammalian lens by growth factors. Invest Ophthalmol Vis Sci. 2004; 45:872-878.
33. Ohkawara B, Shirakabe K, Hyodo-Miura J, et al. Role of the TAK1-NLK-STAT3 pathway in TGF-beta-mediated mesoderm induction. Genes Dev. 2004;18:381-386.
34. Akita S, Akino K, Fukui M. P-II-02 leukemia inhibitory factor gene and vascular endothelial growth factor protein can module embryonic fibroblastic differentiation via GP130-STAT and MAPK signal transduction pathways. Wound Repair Regen. 2004;12:A5.
35. Schulze-Bergkamen H, Brenner D, Krueger A, et al. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology. 2004;39:645-654.
36. Lian JP, Word B, Taylor S, Hammons GJ, Lyn-Cook BD. Modulation of the constitutive activated STAT3 transcription factor in pancreatic cancer prevention: effects of indole-3-carbinol (I3C) and genistein. Anticancer Res. 2004;24:133-137.
37. Seki Y, Suzuki N, Imaizumi M, et al. STAT3 and MAPK in human lung cancer tissues and suppression of oncogenic growth by JAB and dominant negative STAT3. Int J Oncol. 2004;24:931-934.
38. Chan KS, Carbajal S, Kiguchi K, Clifford J, Sano S, DiGiovanni J. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res. 2004;64: 2382-2389.
39. Bharti AC, Shishodia S, Reuben JM, et al. Nuclear factorkappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood. 2004; 103:3175-3184.
40. Kanda N, Seno H, Konda Y, et al. STAT3 is constitutively activated and supports cell survival in association with survival expression in gastric cancer cells. Oncogene. 2004; 23:4921-4929.
41. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res. 1998;74:49-139.
42. Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol. 1999;71:479-500.
43. Wierenga AT, Vogelzang I, Eggen BJ, Vellenga E. Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway. Exp Hematol. 2003;31:398-405.
44. Igarashi A, Nashiro K, Kikuchi K, et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol. 1996;106:729-733.
45. Xiao D, Pearce WJ, Longo LD, Zhang L. ERK-mediated uterine artery contraction: role of thick and thin filament regulatory pathways. Am J Physiol Heart Circ Physiol. 2004;286:H1615-H1622.
46. Allen FD, Asnes CF, Chang P, Elson EL, Lauffenburger DA, Wells A. Epidermal growth factor induces acute matrix contraction and subsequent calpain-modulated relaxation. Wound Repair Regen. 2002;10:67-76.
47. Laine P, Reunanen N, Ravanti L, et al. Activation of extracellular signal-regulated protein kinase1, 2 results in down-regulation of decorin expression in fibroblasts. Biochem J. 2000;349:19-25.
48. Fernandez-Garcia B, Vaque JP, Herreros-Villanueva M, et al. p73 cooperates with Ras in the activation of MAP kinase signaling cascade. Cell Death Differ. 2007;14:254-265.
49. Gana-Weisz M, Halaschek-Wiener J, Jansen B, Elad G, Haklai R, Kloog Y. The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance. Clin Cancer Res. 2002;8:555-565.
50. Daniels JT, Schultz GS, Blalock TD, et al. Mediation of transforming growth factor-beta(1)-stimulated matrix contracted by fibroblasts: a role for connective tissue growth factor in contractile scarring. Am J Pathol. 2003;163(5):2043-2052.
51. Folger PA, Zekaria D, Grotendorst G, Masur SK. Transforming growth factor-beta-stimulated connective tissue growth factor expression during corneal myofibroblast differentiation. Invest Ophthalmol Vis Sci. 2001;42:2534-2541.
52. Saika S, Okada Y, Miyamoto T, et al. Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Invest Ophthalmol Vis Sci. 2004;45:100-109.
53. Leask A, Holmes A, Black CM, Abraham DJ. Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem. 2003;278:13008-13015.
54. Hayashida T, Decaestecker M, Schnaper HW. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J. 2003;17:1576-1578.
55. Noble ME, Endicott JA, Johnson LN. Protein kinase inhibitors: insights into drug design from structure. Science. 2004;303: 1800-1805.